Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

AddLife Yönetim

Yönetim kriter kontrolleri 2/4

AddLife's CEO'su Fredrik Dalborg, Jan2022 tarihinde atandı, in görev süresi 2.75 yıldır. in toplam yıllık tazminatı SEK 8.70M olup, şirket hissesi ve opsiyonları dahil olmak üzere 56.8% maaş ve 43.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.026% ine doğrudan sahiptir ve bu hisseler € 448.23K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.2 yıl ve 9.1 yıldır.

Anahtar bilgiler

Fredrik Dalborg

İcra Kurulu Başkanı

SEK 8.7m

Toplam tazminat

CEO maaş yüzdesi	56.8%
CEO görev süresi	2.8yrs
CEO sahipliği	0.03%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	9.1yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Fredrik Dalborg'un ücretlendirmesi AddLife'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	SEK 118m
Mar 31 2024	n/a	n/a	SEK 78m
Dec 31 2023	SEK 9m	SEK 5m	SEK 190m
Sep 30 2023	n/a	n/a	SEK 292m
Jun 30 2023	n/a	n/a	SEK 387m
Mar 31 2023	n/a	n/a	SEK 429m
Dec 31 2022	SEK 6m	SEK 2m	SEK 480m

Tazminat ve Piyasa: Fredrik 'nin toplam tazminatı ($USD 847.69K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 1.58M ).

Tazminat ve Kazançlar: Fredrik şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.

CEO

Fredrik Dalborg (52 yo)

2.8yrs

Görev süresi

SEK 8,704,000

Tazminat

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fredrik Dalborg	President & CEO	2.8yrs	SEK 8.70m	0.026% € 449.6k
Christina Rubenhag	Chief Financial Officer	2.8yrs	Veri yok	0.0053% € 91.4k
Julie O'Leary	Investor Relations Manager	less than a year	Veri yok	Veri yok
Christian Karlsson	Head of Business Development	3.8yrs	Veri yok	Veri yok
Per Wahlstedt	Head of Organic Growth & Profitability	2.8yrs	Veri yok	Veri yok
Timmy Rosendal	Head of Sustainability	1.2yrs	Veri yok	Veri yok
Nathan Pettitt	Head of Business Unit Hospital	less than a year	Veri yok	Veri yok
Mattias Bengtsson	Head of Business Unit BioMedical & Research	less than a year	Veri yok	Veri yok
Luca Marenzi	Head of Business Unit Hospital	less than a year	Veri yok	Veri yok
Kai Rantanen	Head of Business Unit Diagnostics	less than a year	Veri yok	Veri yok
Anna Bergstrom	Head of Business Unit Homecare	less than a year	Veri yok	Veri yok
Jamilah Wass	Group Financial Controller	no data	Veri yok	Veri yok

0.8yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: 1AD1 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.2 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Birgit Norinder	Independent Director	9.1yrs	SEK 350.00k	0.010% € 177.9k
Eva Elmstedt	Independent Director	3.4yrs	SEK 350.00k	0.0041% € 70.3k
Johan Sjo	Independent Chairman	9.6yrs	SEK 700.00k	0.14% € 2.3m
Håkan Roos	Independent Director	9.3yrs	SEK 350.00k	4.76% € 81.6m
Eva Nilsagard	Independent Director	8.8yrs	SEK 500.00k	0.0046% € 78.4k
Stefan Hedelius	Independent Director	9.1yrs	SEK 350.00k	0.024% € 415.6k

9.1yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1AD1 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.1 yıldır).

AddLife Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Insufficient new directors

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought €1.0m worth of stock

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Recent updates

Second quarter 2024 earnings released: EPS: kr0.59 (vs kr0.26 in 2Q 2023)

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

Insufficient new directors

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023)

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

Dividend of kr0.50 announced

Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022)

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Now 22% undervalued after recent price drop

AddLife AB (publ), Annual General Meeting, May 08, 2024

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 33%

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Independent Director recently bought €1.0m worth of stock

Addlife AB (Publ) Declares Dividend

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr1.20 per share at 1.0% yield

First quarter 2023 earnings released

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

Third quarter 2022 earnings released

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Now 22% undervalued after recent price drop

Second quarter 2022 earnings released

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold €808k worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

Upcoming dividend of kr2.00 per share

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought €552k worth of stock

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Investor sentiment deteriorated over the past week

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold €3.2m worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Independent Chairman recently sold €1.1m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Independent Chairman recently sold €689k worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold €1.4m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021